Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
1991-8-14
pubmed:abstractText
Structural characteristics of major histocompatibility complex class I antigens associated with natural killer (NK)-resistance phenomena were examined. Previous research has shown that transfection of class I genomic DNA clones into class I-deficient, NK-sensitive target cell lines results in transfectants exhibiting class I+, NK-resistant phenotypes. In contrast to the HLA-A3, -B7, -B27, and -Bw58 class I molecules, the HLA-A2 class I molecules were shown not to protect target cells from NK activity. Here we show that this nonprotective phenotype maps to the alpha 1 domain of the HLA-A2 molecule by examining the NK-protective capacity of the natural interdomain recombinant HLA-Aw69 molecule. HLA-Aw69, which consists of an alpha 1 domain exhibiting homology with HLA-Aw68, and alpha 2/alpha 3/transmembrane-cytoplasmic domains, exhibiting homologies with HLA-A2, mimics HLA-Aw68 and provides HLA-A,B null target cell (C1R) transfectants with increased resistance to NK. Further, the inability of transfected HLA-A2 to confer protection against NK activity can be completely attributed to the expression of a "nonpermissive" residue at position 74 in the alpha 1 domain. Site-directed mutation of the His-74 residue in HLA-A2 to the Asp-74 (HLA-A3, -Aw68, -Aw69, -B7) residue generates a mutant that provides C1R cell line transfectants an NK-resistant phenotype. As His-74 blocks access to a side pocket in the HLA-A2 antigen-binding cleft, these results support the critical involvement of residues within the peptide-binding groove of class I molecules in determining the NK susceptibility phenotype of class I+ target cells.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2021423, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2106441, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2109837, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2201309, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2347364, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2426704, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2430177, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2443855, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2459229, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2467945, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2479694, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2493507, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2594067, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2707298, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2784569, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2934137, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2983194, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-2999432, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3104241, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3133413, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3182907, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3264312, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3289570, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3309677, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3711664, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3819393, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3877632, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3877776, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-3951539, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-4133807, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-4343540, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-6395653, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-6399848, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-6463854, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-65285, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-87414, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-92183, http://linkedlifedata.com/resource/pubmed/commentcorrection/2068075-93026
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5989-92
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
pubmed:affiliation
Department of Microbiology, Duke University Medical Center, Durham, NC 27710.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't